84 FR 110 pgs. 26691-26692 - National Cancer Institute Amended; Notice of Meeting
Type: NOTICEVolume: 84Number: 110Pages: 26691 - 26692
Pages: 26691, 26692FR document: [FR Doc. 2019-11954 Filed 6-6-19; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended; Notice of Meeting
[top] Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 17, 2019, 08:00 a.m. to 05:00 p.m.,
This meeting notice is amended to change the name of the meeting from Advancing Cancer Immunotherapy by Mitigating-Immune related adverse events to Advancing Cancer Immunotherapy by Mitigating irAEs. The meeting is closed to the public.
Dated: June 3, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-11954 Filed 6-6-19; 8:45 am]
BILLING CODE 4140-01-P